Similarly, in models of nonalcoholic steatohepatitis (NASH), chemerin improves insulin sensitivity by reducing oxidative stress and activating autophagy via the JAK2-STAT3 pathway—effects reversed by CMKLR1 inhibition [90]. This evidence concerns the gene JAK2 and metabolic dysfunction-associated steatohepatitis.